Cite
HARVARD Citation
Kato, Y. et al. (2018). Combined effect of cabozantinib and gefitinib in crizotinib‐resistant lung tumors harboring ROS1 fusions. Cancer science. 109 (10), pp. 3149-3158. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kato, Y. et al. (2018). Combined effect of cabozantinib and gefitinib in crizotinib‐resistant lung tumors harboring ROS1 fusions. Cancer science. 109 (10), pp. 3149-3158. [Online].